Prevalence of Malnutrition in Oncologic Patients
Prevalence and Impact of Malnutrition in Hospitalised Patients
1 other identifier
observational
400
1 country
1
Brief Summary
Malnutrition is a common phenomenon in cancer patients. Deteriorated nutritional status is associated with poor clinical outcome. The purpose of this study is to determine the prevalence of hospital malnutrition and its impact on functionality, quality of life and mortality in cancer patients and to test the reference percentiles of phase angle values (Bosy Westphal et al JPEN 2006) as indicator of cancer cachexia and predictor of mortality. Hypothesis: The fifth reference percentile of the phase angle norm values is a prognostically relevant cut off value indicating cancer cachexia in terms of malnutrition, fatigue and impaired functional status, as well as predictive of 6-month mortality
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2006
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2007
CompletedFirst Submitted
Initial submission to the registry
May 6, 2010
CompletedFirst Posted
Study publicly available on registry
May 11, 2010
CompletedMay 11, 2010
October 1, 2006
6 months
May 6, 2010
May 10, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of malnutrition
Phase angle (bioelectrical impedance analysis) Nutritional status(SGA), muscle function (grip strength)
1 day
Secondary Outcomes (3)
Quality of life
1 day
Mortality
6 months
Depression
1 day
Eligibility Criteria
Patients will be selected in primary care clinics.
You may qualify if:
- Patients suffering from cancer.
- Patients who have signed a written Informed Consent.
You may not qualify if:
- Patients with implanted pacemaker or defibrillator
- Patients with neuromuscular disease or hemiplegia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Gastroenterology, Charité Universitätsmedizin Berlin, Campus Mitte
Berlin, State of Berlin, 10117, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthias Pirlich, MD
Charite University, Berlin, Germany
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 6, 2010
First Posted
May 11, 2010
Study Start
December 1, 2006
Primary Completion
June 1, 2007
Study Completion
June 1, 2007
Last Updated
May 11, 2010
Record last verified: 2006-10